CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total revenues	$ 653,445	$ 413,104
Expenses:
Medical services expense	566,208	360,354
Other medical expenses	44,773	23,661
General and administrative (including noncash stock-based compensation expense of $3,970 and $1,472, respectively)	39,834	37,777
Depreciation and amortization	3,373	3,427
Total expenses	654,188	425,219
Income (loss) from operations	(743)	(12,115)
Other income (expense):
Other income (expense), net	2,269	1,336
Interest expense	(871)	(2,941)
Income (loss) before income taxes	655	(13,720)
Income tax benefit (expense)	71	(16)
Income (loss) from continuing operations	726	(13,736)
Discontinued operations:
Income (loss) before income taxes	429	(1,351)
Income tax benefit (expense)	0	(64)
Total discontinued operations	429	(1,415)
Net income (loss)	1,155	(15,151)
Noncontrolling interests' share in (earnings) loss	75	73
Net income (loss) attributable to common shares	$ 1,230	$ (15,078)
Net income (loss) per common share, basic and diluted
Continuing operations	$ 0	$ (0.04)
Discontinued operations	$ 0	$ (0.01)
Basic	401,964	325,659
Diluted	424,065	325,659
Medical Services Revenue
Revenues:
Total revenues	$ 652,423	$ 412,412
Other Operating Revenue
Revenues:
Total revenues	$ 1,022	$ 692